share_log
Reuters ·  May 1 07:00
Cullinan Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment